US health – Ghana turned down a proposed U.S. health agreement, citing concerns that it would grant U.S. access to sensitive health data without adequate safeguards.
A proposed U.S. health deal was rejected by Ghana after the country raised sharp concerns about how sensitive health data would be shared with American entities.
Ghana’s Data Protection Commission said the terms would have allowed broader access than what would typically be needed for the stated purpose. with safeguards and oversight described as insufficient.. The decision. outlined by a senior official at the commission. adds Ghana to a growing list of countries weighing back against similar arrangements.
This is one of those moments where public health funding collides with privacy governance. As more aid and research efforts rely on digital data, the question becomes not only whether countries get support, but whether they retain control over who can use information tied to individuals’ lives.
Under the proposed agreement, Ghana would have received substantial U.S.. funding over several years, alongside additional investment from the Ghanaian government.. However. the commission objected to provisions that it said would have expanded access beyond raw health records. including information structures and reporting tools that shape how data is interpreted and used.
The official said Ghana would not have had meaningful prior approval over how data would be utilized. describing the approach as effectively delegating parts of the country’s health data architecture.. The proposed terms also contemplated multiple U.S.. entities accessing the data, with Ghana arguing it lacked the governance needed to oversee usage in advance.
Meanwhile, officials at the U.S. State Department did not immediately address the concerns raised by Ghana regarding the deal’s data-sharing scope.
Ghana’s refusal comes as other African nations have also questioned similar health arrangements over data privacy and sovereignty.. Activists have warned that inadequate safeguards can undermine public trust. and some advocates say the agreements can limit control over healthcare systems or shift resources in ways that do not fully reflect local priorities.
This latest rejection matters because it signals a potential turning point for how international health financing is structured.. If more countries insist on tighter controls and stronger approval mechanisms. future deals may need to be redesigned around governance standards rather than assumptions that funding alone resolves accountability gaps.
In this context, Ghana says it communicated its decision to the U.S. and is seeking improved conditions for any better deal moving forward. Whether negotiations shift toward stronger privacy protections will likely shape how other countries view similar offers.